The Week in Review in Drug Pricing

Summer temperatures and drug prices rise. PBMs see dramz. And a slap on the wrist that (hopefully) stings.

Short week. Short week in review. Enjoy!

1. Pfizer can’t stop won’t stop...hiking drug prices

Nosy reporters this week noticed the pharmaceutical behemoth ignored pleas from the nation’s top officials to stop hiking drug prices, and hiked prices. — (Washington Examiner

2. PBM dramz

Myth or fact: PBMs keep prices high to maintain profits, instead of bargaining with drug corporations for lower prices. Inquiring senators want to know.  — (Fierce HealthCare)

3. A $488 million dollar slap on the wrist

If it hurts, we’re sure there’s an overpriced pill to ease AbbVie’s pain. — (STAT)

4. Who invited the Pharma CEOs?

President Trump invited heads of pharmaceutical corporations to a private dinner in London. — (Endpoints News)

Have a great weekend, everyone!